Nasal Immunization by (PLGA) Nanospheres Encapsulated with Tetanus Toxoid and (CpG-ODN)

Mohsen Tafaghodi; Seyed Abolghasem Sajadi Tabassi; Mahmoud Reza Jaafari

doi:10.22037/ijpr.2010.715

IJ Pharmaceutical Research

Home

Search Instructions

APC

Authors Guide Submit Manuscript

Outlines

Abstract
Copyright

https://doi.org/10.22037/ijpr.2010.715

Nasal Immunization by (PLGA) Nanospheres Encapsulated with Tetanus Toxoid and (CpG-ODN)

Author(s):

Mohsen Tafaghodi^{1, 2,*},

Seyed Abolghasem Sajadi Tabassi^{1, 3},

Mahmoud Reza Jaafari^{1, 4}

1School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

2Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran

4Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

IJ Pharmaceutical Research:Vol. 6, issue 3; 151-158

Published online:Nov 20, 2010

Article type:Research Article

Received:Sep 21, 2006

Accepted:Mar 21, 2007

How to Cite:Tafaghodi M, Sajadi Tabassi SA, Jaafari MR. Nasal Immunization by (PLGA) Nanospheres Encapsulated with Tetanus Toxoid and (CpG-ODN). Iran J Pharm Res. 2022;6(3):e128326. doi: https://doi.org/10.22037/ijpr.2010.715

Abstract

In induction of systemic and mucosal immunity, particulate antigens are more effective than soluble antigens possibly because they are more efficiently endocytosed by mucosal-associated lymphoid tissue (MALT) M cells. In this study, we determined the systemic and mucosal immune responses in rabbits following intranasal immunization of tetanus toxoid TT and CpG-ODN encapsulated within PLGA nanospheres. The mean diameter of (TT) and TT+CpG nanospheres were 753±193 and 684±324 nm, respectively. Encapsulation efficiency of TT and CpG-ODN was determined as 52±7.8% and 30.2±7.4%, respectively. The highest nasal lavage (sIgA) titers were observed in groups immunized with nanosphere formulations, while the IgG and antitoxin titers were suppressed by these formulations. CpG-ODN as an adjuvant could increase the serum IgG and antitoxin titers when co-administered with TT solution or co-encapsulated with TT in PLGA nanospheres, but failed to potentiate the IgA titers in nasal lavages. No hemolysis was occurred on incubation of PLGA nanospheres and human (RBCs). Also after nasal administration of plain nanospheres to human volunteers, no local irritation was seen. Intranasal administration of nanospheres encapsulated with vaccines showed to be an effective way for inducing mucosal sIgA immune responses, and CpG-ODN could increase the systemic immune responses.

Keywords

Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid

Faezeh Moghadam Ariaee,

Mohsen Tafaghodi

Moghadam Ariaee F, Tafaghodi M. Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid. Iran J Pharm Res. 2012;11(3):e125829. doi: https://doi.org/10.22037/ijpr.2012.1119

6

Jan

2025

Investigating the Immunogenicity of PA63 Antigen in Free form and Loaded in PLGA Nanoparticle in Mice

Hossein Honari,

Mohammad Ebrahim Minaei

Honari H, Minaei ME. Investigating the Immunogenicity of PA63 Antigen in Free form and Loaded in PLGA Nanoparticle in Mice. koomesh. 2024;26(4):e149879. doi: https://doi.org/10.69107/koomesh-149879

6

Dec

2025

Test

Sanaz Omrani

Omrani S. Test. faplusdemo. 2024;درحال انتشار(درحال انتشار):e168861. doi:

26

Dec

2015

Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles

Iraj Khalili,

Rahim Ghadimipour,

Saeed Sadigh Eteghad,

Mohsen Fathi Najafi,

Mohammad Majid Ebrahimi,

Naser Godsian

,et al.

Khalili I, Ghadimipour R, Sadigh Eteghad S, Fathi Najafi M, Ebrahimi MM, et al. Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles. Jundishapur J Microbiol. 2015;8(12):e27035. doi: https://doi.org/10.5812/jjm.27035

20

Nov

2010

Preparation and Evaluation of Diphtheria Toxoid-Containing Microspheres

Seyed Alireza Mortazavi,

Ali Rezaei Mokarram

Mortazavi SA, Rezaei Mokarram A. Preparation and Evaluation of Diphtheria Toxoid-Containing Microspheres. Iran J Pharm Res. 2022;3(3):e128196. doi: https://doi.org/10.22037/ijpr.2010.590

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 2 weeks ago
Scopus by Title: 7
Last Update: 2 weeks ago
Scopus by Title (Ref): 0
Last Update: 2 weeks ago
CrossRef: 0
Last Update: 2 days ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Mohsen Tafaghodi:[PubMed][Scholar]
Seyed Abolghasem Sajadi Tabassi:[PubMed][Scholar]
Mahmoud Reza Jaafari:[PubMed][Scholar]

Outlines

Nasal Immunization by (PLGA) Nanospheres Encapsulated with Tetanus Toxoid and (CpG-ODN)

Abstract

Similar Articles

Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid

Investigating the Immunogenicity of PA63 Antigen in Free form and Loaded in PLGA Nanoparticle in Mice

Test

Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles

Preparation and Evaluation of Diphtheria Toxoid-Containing Microspheres

Crossmark

Checking

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 2 days ago